EUROSERPIN2025 Programme (provisional)

 

Monastero di San Faustino Maggiore, Brescia, 28-30 May 2025

 

 

Wednesday 28th May 2025

 

 


13:00-14:00        Registration

 


14:00-14:15        Welcome address

 

 

Session 1 - Serpins in health and disease I - 14:15-17:40

 

 


Robin Carrell
(University of Cambridge, UK)



Stefan Marciniak (University of Cambridge, UK)
Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency

 

 

Rick Sifers (Baylor College of Medicine, USA)
Utilization of SERPINA1 and patient genetics to elucidate the regulation of the Hepatocyte Proliferation Response

 

 

Sonia Caccia (University of Milan, Italy)
Impact of C1-inhibitor binding to endothelial cells on the regulation of vascular permeability

 

 

Coffee break

 

 

Sabina Janciauskiene (Hannover Medical School, Germany)
α-1-Antitrypsin C-terminal peptides: biomarkers and therapeutic targets in disease

 

 

Javier Corral (University of Murcia-IMIB, Spain)
Antithrombin deficiency update. What's up doc?

 

 

John Heiker (Helmholtz Munich, Germany)
DNA binding of vaspin (SERPINA12)

 

 

Speakers to be selected from abstracts

 

 

 

Thursday 29th May 2025

 

 

 

Session 2 – Therapies, diagnostics and disease models - 9:00-13:00

 

 


David Lomas
 (University College London, UK)
Towards a small molecule therapy for alpha-1 antitrypsin deficiency

 

 

Patrizia Pontisso (University of Padova, Italy)

Title TBD

 

 

Speakers to be selected from abstracts

 

 

Coffee break

 

 

Alexandra Lucas (Arizona State University, USA)

Title TBD

 

 

Tamir Rashid (Imperial College London, UK)
Induced pluripotent stem cell therapies

 

 

Beatriz Martinez Delgado (Carlos III Health Institute, Spain)
Metabolic alterations in AATD cellular models and patient-derived liver organoids

 

 

Speakers to be selected from abstracts

 

 

 

13:00-14:00        Lunch (provided)

 

 

 

14:00-15:30        Poster session

 

 

 

 

Session 3 - Serpins in health and disease II - 15:30-17:30

 

 


Maurizio Molinari
 (IRB USI, Switzerland)
Understanding the molecular mechanisms of lysosomal clearance of ATZ polymers

 

 

Marie-Christine Bouton (INSERM Paris, France)
Specific platelet targeting of serpinE2 for haemophilia treatment

 

 

Malin Fromme (University Hospital RWTH Aachen, Germany)

Title TBD

 

 

Bibek Gooptu (University of Leicester, UK)

Title TBD

 

 

Speakers to be selected from abstracts

 

 

 

18:00                Meeting dinner

 

 

 

 

Friday 30th May 2025

 

 

 

Session 4 - Structural and molecular mechanisms - 9:00-13:00

 

 


Lisa Cabrita
 (University College London, UK)

Title TBD

 

Giuseppe Legname (SISSA, Italy)
The role of SERPINA3 in the pathology of prion disorders

 

 

Speakers to be selected from abstracts

 

 

Coffee break

 

 

Aiwu Zhou (Shanghai Jiaotong University, China)
How the specificity of kallistatin is modulated by heparin

 

 

Konstantinos Thalassinos (University College London, UK)
Top-down ion mobility mass spectrometry reveals a disease associated conformational ensemble of alpha-1-antitrypsin

 

 

Nunzia Pastore (TIGEM, Italy)

Title TBD

 

 

Adriana Ordoñez (HiTech, Catholic University of San Antonio of Murcia)
Uncovering adaptive genes that mitigate serpin polymerization toxicity and their link to the unfolded protein response

 

                

Speakers to be selected from abstracts

 

 

 

13:00-14:00        Lunch (provided)

 

 

 

 

Session 5 - Applications, tools and new perspectives - 14:00-16:30

 

 


Federica Michielin
(UCL - GOS Institute of Child Health London, UK)

Modelling Alpha-1 antitrypsin deficiency with patient-derived hepatic organoids.

 

 

Ilaria Ferrarotti (University of Pavia, Italy)
Title TBD

 

 

Ilaria Fregno (IRB USI, Switzerland)
ERAD vs ERLAD: Degradation of misfolded α1AT variants from the ER

 

 

Speakers to be selected from abstracts

 

 

Concluding remarks

 

 

 

 

 

Current as of April 21st, 2025